Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

PHASE3CompletedINTERVENTIONAL
Enrollment

427

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Prevention
Interventions
DRUG

Esomeprazole

20mg, capsule, 72 weeks

DRUG

Placebo

Placebo, capsule, 72 weeks

Trial Locations (46)

Unknown

Research Site, Yotsukaidou

Research Site, Fukui-shi

Research Site, Fukuoka

Research Site, Kitakyushu-Shi

Research Site, Onga-Gun

Research Site, Yukuhashi

Research Site, Fukushima

Research Site, Kōriyama

Research Site, Nihommatsu

Research Site, Fukuyama

Research Site, Kure

Research Site, Sapporo

Research Site, Amagasaki

Research Site, Itami

Research Site, Kobe

Research Site, Nishinomiya

Research Site, Higashi-ibaraki,

Research Site, Komatsu

Research Site, Nomi

Research Site, Kawasaki-shi

Research Site, Yokohama

Research Site, Uji

Research Site, Sendai

Research Site, Daitō

Research Site, Kishiwada

Research Site, Matsubara

Research Site, Minato

Research Site, Yao

Research Site, Hanyū

Research Site, Shizuoka

Research Site, Shimotsuke

Research Site, Chūō

Research Site, Minato

Research Site, Shinagawa

Research Site, Shinjuku

Research Site, Shimonoseki

Research Site, Gangneung

Research Site, Wŏnju

Research Site, Seongnam-si

Research Site, Busan

Research Site, Seoul

Research Site, Niao-Song-Shiang

Research Site, Kweishan Shiang

Research Site, Kaohsiung City

Research Site, Tainan City

Research Site, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY